|
KMID : 1141920240400020089
|
|
Annals of Coloproctology
2024 Volume.40 No. 2 p.89 ~ p.113
|
|
|
Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
|
|
Ryu Hyo-Seon
Kim Hyun-Jung
Ji Woong-Bae
Kim Byung-Chang
Kim Ji-Hun
Moon Sung-Kyung
Kang Sung-Il
Kwak Han-Deok
Kim Eun-Sun
Kim Chang-Hyun
Kim Tae-Hyung
Noh Gyoung-Tae
Park Byung-Soo
Park Hyeung-Min
Bae Jeong-Mo
Bae Jung-Hoon
Seo Ni-Eun
Song Chang-Hoon
Ahn Mi-Sun
Eo Jae-Seon
Yoon Young-Chul
Yoon Joon-Kee
Lee Kyung-Ha
Lee Kyung-Hee
Lee Kil-Yong
Lee Myung-Su
Lee Sung-Hak
Lee Jong-Min
Lee Ji-Eun
Lee Han-Hee
Ihn Myong-Hoon
Jang Je-Ho
Jeon Sun-Kyung
Chae Kum-Ju
Choi Jin-Ho
Pyo Dae-Hee
Ha Gi-Won
Han Kyung-Su
Hong Young-Ki
Hong Chang-Won
Kwak Jung-Myun
|
|
|
Abstract
|
|
|
|
Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.
|
|
|
KEYWORD
|
|
|
Colonic neoplasms, Diagnosis, Genetics, Therapy, Humans
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|